ArticleJournal for immunotherapy of cancer2024

Infliximab in steroid-refractory immune-related hepatitis does not demonstrate hepatotoxicity and may shorten time on steroids.

Elias Burri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.